Anupam Rasayan India Limited has signed Letter of Intent worth revenue of $265 million (INR 21,860 million) for next 5 years with one of the leading Japanese Speciality Chemical company to supply new age patented life science active ingredient. The product will be in validation phase for the next eighteen months and upon the successful validation, the supply will commence from calendar year 2025. This product will be manufactured in existing multipurpose manufacturing facilities.